Altamira Therapeutics Ltd. Current Portion Of Longterm Borrowings
Altamira Therapeutics Ltd. (CYTOF) had Current Portion Of Longterm Borrowings of $430.84 thousand as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:CurrentPortionOfLongtermBorrowings · last filed 2025-08-29
- 2023-06-30: Current Portion Of Longterm Borrowings 2.13M CHF.
- 2022-12-31: Current Portion Of Longterm Borrowings 5.87M CHF.
- 2022-06-30: Current Portion Of Longterm Borrowings 4.70M CHF.
- 2020-12-31: Current Portion Of Longterm Borrowings 523.92K CHF.
CHF
| Period end | Current Portion Of Longterm Borrowings |
|---|---|
| 2023-06-30 | 2.13M CHF 6-K · filed 2023-09-12 |
| 2022-12-31 | 5.87M CHF 20-F/A · filed 2024-04-22 |
| 2022-06-30 | 4.70M CHF 6-K/A · filed 2023-08-21 |
| 2020-12-31 | 523.92K CHF 20-F · filed 2022-04-12 |
| 2018-12-31 | 1.44M CHF 20-F · filed 2020-04-16 |
| 2017-12-31 | 4.54M CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 2.21M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Current Portion Of Longterm Borrowings |
|---|---|
| 2025-06-30 | $430.84K 6-K · filed 2025-08-29 |
| 2023-01-01 | $6.35M 20-F · filed 2025-04-30 |